The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer

Thromboembolic disease has long been recognized as a complication of cancer. Recent reports have suggested that drugs used in the treatment of cancer, including chemotherapeutic agents and hormones, may contribute to this risk, but it has not been possible to separate the effect of these drugs from...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 1988-02, Vol.318 (7), p.404-407
Hauptverfasser:	Levine, Mark N, Gent, Michael, Hirsh, Jack, Arnold, Andrew, Goodyear, Michael D, Hryniuk, William, De Pauw, Sonja
Format:	Artikel
Sprache:	eng
Schlagworte:	5-Fluorouracil Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Breast cancer Breast Neoplasms - complications Breast Neoplasms - drug therapy Cancer therapies Chemotherapy Cyclophosphamide Cyclophosphamide - administration & dosage Doxorubicin Doxorubicin - administration & dosage Drug Administration Schedule Drug toxicity and drugs side effects treatment Female Fluorouracil - administration & dosage Health risk assessment Humans Mastectomy Medical sciences Methotrexate Methotrexate - administration & dosage Middle Aged Pharmacology. Drug treatments Prednisone Prednisone - administration & dosage Pulmonary Embolism - chemically induced Random Allocation Tamoxifen Tamoxifen - adverse effects Thromboembolism Thrombosis Thrombosis - chemically induced Time Factors Toxicity: cardiovascular system Vincristine Vincristine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!